Sector consensus GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
19:05:08 17/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,799.90 INR | -1.97% |
|
-3.12% | +13.19% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,324.87 | +16.44% | 29 | ||||||
| 277.91 | +3.98% | 22 | ||||||
| 278.61 | +6.13% | 28 | ||||||
| 374.61 | +3.34% | 19 | ||||||
| 152.93 | +9.61% | 22 | ||||||
| 210.56 | +29.01% | 23 | ||||||
| 383.19 | +1.82% | 27 | ||||||
| 310.17 | +13.78% | 23 | ||||||
| 158.15 | +7.09% | 27 | ||||||
| 28.88 | +5.15% | 26 | ||||||
| 569.19 | +10.9% | 27 | ||||||
| 66.71 | +4.89% | 24 | ||||||
| 94.06 | +26.51% | 24 | ||||||
| 21.71 | +16.38% | 21 | ||||||
| 9,323.33 | +44.64% | 15 | ||||||
| 6,603.31 | +12.94% | 16 | ||||||
| 58.22 | +18.87% | 18 | ||||||
| 71.35 | +63.96% | 17 | ||||||
| Average | 1,128.21 | +16.41% | 23 | ||||||
| Weighted average by Cap. | 721.27 | +11.83% | 25 |
Select your edition
All financial news and data tailored to specific country editions
